Wearable Microneedle Patch Delivers Peptide Drugs Continuously for 24+ Hours Without Electronics
A wearable osmotic microneedle patch maintained stable semaglutide blood levels for 24+ hours in animal models using osmotic pressure — no batteries, pumps, or electronics required.
Quick Facts
What This Study Found
Osmotic microneedle (OMN) patch achieved sustained drug delivery for ≥24 hours in animal models, maintaining stable plasma concentrations without electronic components.
Key Numbers
Three hollow microneedles with diameters less than 200 micrometers; sustained drug delivery for at least 24 hours.
How They Did This
Developed osmotic-driven microneedle patch. Characterized drug release kinetics in vitro. Tested sustained drug delivery and plasma pharmacokinetics in animal models.
Why This Research Matters
Peptide drugs like semaglutide and insulin require injections because they cannot be taken orally in most cases. A painless, wearable patch that delivers peptides continuously could transform patient experience and improve drug effectiveness.
The Bigger Picture
The peptide drug delivery market is rapidly growing as more peptide therapeutics are approved. Current delivery is dominated by injections, which limit patient acceptance. Osmotic microneedle patches could make peptide therapy as simple as wearing a bandage, potentially improving adherence for chronic conditions.
What This Study Doesn't Tell Us
Animal study — skin thickness and drug absorption differ in humans. Drug loading capacity for larger peptides needs evaluation. Patch adhesion and comfort over 24 hours in real-world conditions not yet tested in humans.
Questions This Raises
- ?Can the OMN patch deliver clinically relevant doses of semaglutide or insulin in humans?
- ?How does patch adhesion and comfort compare to current injection methods over extended wear?
- ?Could this technology enable continuous delivery of peptides that currently require multiple daily injections?
Trust & Context
- Key Stat:
- 24+ hour delivery Wearable microneedle patch maintains stable peptide drug levels using osmotic pressure, eliminating the need for injections
- Evidence Grade:
- Preliminary evidence: proof-of-concept in animal models with promising drug delivery kinetics, but no human data.
- Study Age:
- Published in 2024. Addresses a growing need for non-injection peptide delivery.
- Original Title:
- A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models.
- Published In:
- Science translational medicine, 16(775), eadp3611 (2024)
- Authors:
- Zhao, Sheng(2), Lu, Ziyi, Cai, Ruisi, Wang, Hui, Gao, Shukun, Yang, Changwei, Zhang, Ying, Luo, Bowen, Zhang, Wentao, Yang, Yinxian, Wang, Shenqiang, Sheng, Tao, Wang, Shiqi, You, Jiahuan, Zhou, Ruyi, Ji, Huimin, Gong, Haoning, Ye, Xiao, Yu, Jicheng, Zhu, Hong-Hu, Zhang, Yuqi, Gu, Zhen
- Database ID:
- RPEP-09670
Evidence Hierarchy
Frequently Asked Questions
How does the microneedle patch work?
Tiny needles on the patch penetrate only the very top layer of skin (painlessly). Osmotic pressure from tissue fluid entering the patch naturally pushes the drug out at a controlled rate, maintaining steady blood levels for 24+ hours — like a self-powered drug pump.
Could this replace weekly semaglutide injections?
Potentially — if the patch can deliver enough drug in humans. A daily or multi-day patch could replace weekly injections for peptide drugs, making treatment more convenient and potentially improving how well the drug works by maintaining steadier blood levels.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09670APA
Zhao, Sheng; Lu, Ziyi; Cai, Ruisi; Wang, Hui; Gao, Shukun; Yang, Changwei; Zhang, Ying; Luo, Bowen; Zhang, Wentao; Yang, Yinxian; Wang, Shenqiang; Sheng, Tao; Wang, Shiqi; You, Jiahuan; Zhou, Ruyi; Ji, Huimin; Gong, Haoning; Ye, Xiao; Yu, Jicheng; Zhu, Hong-Hu; Zhang, Yuqi; Gu, Zhen. (2024). A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models.. Science translational medicine, 16(775), eadp3611. https://doi.org/10.1126/scitranslmed.adp3611
MLA
Zhao, Sheng, et al. "A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models.." Science translational medicine, 2024. https://doi.org/10.1126/scitranslmed.adp3611
RethinkPeptides
RethinkPeptides Research Database. "A wearable osmotic microneedle patch provides high-capacity ..." RPEP-09670. Retrieved from https://rethinkpeptides.com/research/zhao-2024-a-wearable-osmotic-microneedle
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.